CD44 is particularly expressed by AML-LSCs and CLL cells which take advantage of HA-CD44 signaling to promote leukemic survival via PI3K/AKT and MAPK/ERK pathways (257, 322). The gene discussed is CD44; the disease is acute myeloid leukemia.